Tianyin Pharmaceutical, whose fiscal year ends in two weeks on June 30, announced it expects to report revenues of $42 million and net income of $7.5 million in its 2009 fiscal year. Both numbers reflect an increase of 25% over year earlier results. Tianyin also issued guidance for further growth of 40% in fiscal 2010. More details...

Stock Symbol: (NYSE AMEX: TPI)